KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Other Accumulated Expenses (2016 - 2025)

Biogen has reported Other Accumulated Expenses over the past 17 years, most recently at $2.8 billion for Q4 2025.

  • Quarterly results put Other Accumulated Expenses at $2.8 billion for Q4 2025, changed 0.18% from a year ago — trailing twelve months through Dec 2025 was $2.8 billion (changed 0.18% YoY), and the annual figure for FY2025 was $2.8 billion, changed 0.18%.
  • Other Accumulated Expenses for Q4 2025 was $2.8 billion at Biogen, up from $2.8 billion in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for BIIB hit a ceiling of $3.8 billion in Q3 2023 and a floor of $2.2 billion in Q1 2022.
  • Median Other Accumulated Expenses over the past 5 years was $2.6 billion (2021), compared with a mean of $2.7 billion.
  • Biggest five-year swings in Other Accumulated Expenses: rose 29.61% in 2022 and later dropped 28.22% in 2024.
  • Biogen's Other Accumulated Expenses stood at $2.5 billion in 2021, then decreased by 0.54% to $2.5 billion in 2022, then increased by 4.05% to $2.6 billion in 2023, then grew by 7.02% to $2.8 billion in 2024, then dropped by 0.18% to $2.8 billion in 2025.
  • The last three reported values for Other Accumulated Expenses were $2.8 billion (Q4 2025), $2.8 billion (Q3 2025), and $2.7 billion (Q2 2025) per Business Quant data.